Zobrazeno 1 - 10
of 141
pro vyhledávání: '"C. Gastaldon"'
Autor:
D. Papola, C. Miguel Sanz, M. Mazzaglia, P. Franco, F. Tedeschi, S. A. Romero, A. R. Patel, G. Ostuzzi, C. Gastaldon, E. Karyotaki, M. Harrer, M. Purgato, M. Sijbrandij, V. Patel, T. A. Furukawa, P. Cuijpers, C. Barbui
Publikováno v:
European Psychiatry, Vol 67, Pp S50-S51 (2024)
Introduction Generalized anxiety disorder (GAD) is one of the most common mental disorders in adults. Psychotherapies are among the most recommended treatment choices for GAD, but which should be considered as first-line treatment still needs to be c
Externí odkaz:
https://doaj.org/article/dbd3407198234ede93617075e4e19ede
Publikováno v:
European Psychiatry, Vol 67, Pp S65-S66 (2024)
Introduction Since its first publication in 1977, the World Health Organization’s (WHO) Model List of Essential Medicines (EML) has guided the national procurement of medicines deemed essential to inform public health policy worldwide. Aiming to in
Externí odkaz:
https://doaj.org/article/4a2f0f51e3dd417e8277f769a9989ea6
Autor:
C. Gastaldon, G. Schoretsanitis, E. Arzenton, E. Raschi, D. Papola, G. Ostuzzi, U. Moretti, E. Seifritz, J. M. Kane, G. Trifirò, C. Barbui
Publikováno v:
European Psychiatry, Vol 66, Pp S95-S96 (2023)
Introduction Antidepressant discontinuation may cause withdrawal syndrome in some cases. However, evidence on this syndrome related to individual antidepressants is limited, as well as about individual risk factors for severe reactions. Objectives To
Externí odkaz:
https://doaj.org/article/1eeff67153494c319f1e8664ad212495
Autor:
C. Gastaldon, E. Arzenton, E. Raschi, O. Spigset, D. Papola, G. Ostuzzi, U. Moretti, G. Trifirò, C. Barbui, G. Schoretsanitis
Publikováno v:
European Psychiatry, Vol 66, Pp S96-S96 (2023)
Introduction Evidence on neonatal withdrawal syndrome following antidepressant intrauterine exposure is limited, particularly for antidepressants other than selective serotonin reuptake inhibitors (SSRIs). Objectives To ascertain whether maternal ant
Externí odkaz:
https://doaj.org/article/439d46dfc8e047929e83b0a9787498c4
Publikováno v:
European Psychiatry, Vol 64, Pp S150-S151 (2021)
Introduction The approval of the esketamine nasal spray for treatment-resistant depression in March 2019 by the Food and Drug Administration (FDA), and few months later by the European Medicine Agency, triggered a vivid debate and many concerns, main
Externí odkaz:
https://doaj.org/article/5d3c8b1aaffa4cdfb6708d4dc647f5b1
Publikováno v:
European Psychiatry, Vol 64, Pp S93-S93 (2021)
Introduction People with coronavirus disease (COVID-19) may frequently require treatment with psychotropic medications, but the underlying medical condition and possible interaction with medical treatments might pose serious safety issues. Objectiv
Externí odkaz:
https://doaj.org/article/6f3607ee6f2c4959a5b21471e5dda2ee
Autor:
D. Papola, G. Ostuzzi, C. Gastaldon, M. Purgato, C. Del Giovane, A. Pompoli, E. Karyotaki, M. Sijbrandij, T. Furukawa, P. Cuijpers, C. Barbui
Publikováno v:
European Psychiatry, Vol 64, Pp S118-S118 (2021)
Introduction Panic disorder is among the most prevalent anxiety diseases. Although psychotherapy is recommended as first-line treatment for panic disorder, little is known about the relative efficacy of different types of psychotherapies. Objective
Externí odkaz:
https://doaj.org/article/e394081b96f1486294dfa8a81a7ad8aa
Publikováno v:
International Review of Psychiatry. 35:180-193
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.